CorVista System with PH Add-On vs prolaio eVO2peak Module

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 68/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

CorVista System with PH Add-On

by CorVista Health

prolaio eVO2peak Module

by Prolaio

AI Verdict

These tools are adjacent rather than direct competitors, as they address different aspects of cardiovascular health. The CorVista System focuses on rapid, non-invasive diagnosis of coronary artery disease and pulmonary hypertension at the point of care. In contrast, the prolaio eVO2peak Module estimates peak oxygen consumption from remote wearable sensor data, serving as an adjunctive aid for broader cardiovascular evaluation and research.

Choose CorVista System with PH Add-On if…

Choose CorVista System with PH Add-On if you require a rapid, non-invasive, point-of-care diagnostic solution for immediate assessment of coronary artery disease and pulmonary hypertension. This system is ideal for clinical settings where quick results are crucial and patient preparation for traditional diagnostic methods (like fasting or exercise) is impractical or undesirable.

View CorVista System with PH Add-On →

Choose prolaio eVO2peak Module if…

Choose prolaio eVO2peak Module if you need to estimate peak oxygen consumption (eVO2peak) longitudinally using real-world data from FDA-cleared wearable sensors. This tool is best suited for cardiovascular research and long-term patient management, providing adjunctive insights from continuous, remote data collection to aid in clinical evaluation.

View prolaio eVO2peak Module →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	CorVista System with PH Add-On	prolaio eVO2peak Module
Pricing	Unknown	Contact for pricing
Deployment	Cloud-based, point-of-care system.	Cloud-based (software-only, processes remote sensor data)
FDA Status	1 AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CorVista System with PH Add-On

Tool A, the CorVista System, offers superior usability due to its completely non-invasive nature, eliminating the need for radiation, contrast agents, injections, fasting, or exercise. It provides rapid results within minutes at the point of care, streamlining the patient experience and clinical workflow.

Clinical Value

CorVista System with PH Add-On

Both tools are FDA-cleared and offer significant clinical value. However, Tool A provides a direct, rapid diagnostic assessment for critical cardiovascular diseases like coronary artery disease and pulmonary hypertension with high sensitivity, specificity, and a negative predictive value of >99% for PH, even detecting PH when other methods fail.

Pricing & Value

CorVista System with PH Add-On

While both tools require contacting for pricing, Tool A has published a cost economic analysis demonstrating its economic benefits and potential for cost savings by integrating seamlessly into the existing cardiovascular diagnostic workflow and reducing the need for more expensive care.

Enterprise Readiness

Tie

Both tools demonstrate strong enterprise readiness, being cloud-based, FDA-cleared, and likely HIPAA compliant with BAAs. Tool A's modular design and 'medical-device-as-a-service' model offer scalability, while Tool B's 'software-only' nature and processing of remote sensor data provide flexibility for integration into diverse remote monitoring programs without proprietary hardware at every site.

Innovation

CorVista System with PH Add-On

Both tools are innovative in their respective domains. However, Tool A represents a more significant paradigm shift by pioneering a completely non-invasive, rapid, point-of-care diagnostic solution for complex cardiovascular conditions, directly replacing more burdensome traditional diagnostic methods.

Support & Docs

prolaio eVO2peak Module

Tool B provides more explicit mentions of technical support for its users, including support for study participants and a direct contact email for inquiries. Its FDA documentation also specifically mentions instructions for integration and intended context of use.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	CorVista System with PH Add-On	prolaio eVO2peak Module
Product Name	CorVista System with PH Add-On	prolaio eVO2peak Module
Company	Analytics for Life	Prolaio
Primary Function/Purpose	FDA-cleared, non-invasive, point-of-care AI diagnostic platform for rapid assessment of coronary artery disease and pulmonary hypertension using machine-learned algorithms.	FDA-cleared software to estimate peak oxygen consumption using real-world patient data for cardiovascular research and care.
Key Input Data/Methodology	Analyzes cardiac and hemodynamic signals; no radiation, contrast agents, injections, fasting, or exercise required. Uses machine-learned algorithms.	Utilizes demographic data, single-lead ECG, and triaxial accelerometry inputs from qualified third-party FDA-cleared wearable medical sensors. Applies a locked deep-learning model.
Key Output/Assessment	Rapid assessment of coronary artery disease and pulmonary hypertension. Rapid results available within minutes.	Estimates peak oxygen consumption (eVO2peak). Provides information as an adjunctive aid in clinical evaluation.

Videos

Demos, reviews, and walkthroughs featuring CorVista System with PH Add-On and prolaio eVO2peak Module.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications of the CorVista System with PH Add-On compared to the prolaio eVO2peak Module?

The CorVista System with PH Add-On is designed for the rapid, non-invasive assessment of coronary artery disease (CAD) and pulmonary hypertension (PH) at the point of care. In contrast, the prolaio eVO2peak Module estimates peak oxygen consumption (eVO2peak) using real-world patient data, serving as an adjunctive aid in the clinical evaluation of patients for cardiovascular research and care.

How do the data collection methods and patient requirements differ between the two tools?

The CorVista System with PH Add-On non-invasively collects cardiac and hemodynamic signals at the point of care, requiring no radiation, contrast agents, injections, fasting, or exercise. The prolaio eVO2peak Module, an all-software medical device, processes demographic data, single-lead ECG, and triaxial accelerometry inputs from qualified third-party FDA-cleared wearable medical sensors.

What specific clinical insights or outputs do these tools provide to aid in patient evaluation?

The CorVista System with PH Add-On provides rapid results within minutes, indicating the likelihood of coronary artery disease and pulmonary hypertension. The prolaio eVO2peak Module estimates peak oxygen consumption (eVO2peak), offering this information as an adjunctive aid for qualified clinicians to interpret alongside other standard-of-care clinical findings.

How do these tools leverage AI and machine learning in their respective analyses?

The CorVista System with PH Add-On utilizes machine-learned algorithms to analyze cardiac and hemodynamic signals for the rapid assessment of CAD and PH. The prolaio eVO2peak Module applies a locked deep-learning model to estimate eVO2peak from demographic data, single-lead ECG, and triaxial accelerometry inputs collected from wearable sensors.

What kind of data do these systems process?

The CorVista System with PH Add-On analyzes cardiac and hemodynamic signals collected directly at the point of care. The prolaio eVO2peak Module processes demographic data, single-lead ECG, and triaxial accelerometry data obtained from qualified third-party FDA-cleared wearable medical sensors.